Skip to content

Zwitserse Apotheek

Active Private limited companyfounded 1968active for 58 yearsTurnhoutsebaan 317, 2110 WijnegemKBO/BCE: BE 0403.785.165 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 48 filings since 1977
peak of €279,169 in 2022
€250,482▲ 26.0%
lowest -€33,386 in 2012
€37,798▲ €58,173
peak of €329,373 in 2022
€319,298▲ 13.4%
€212,347▼ 1.9%
peak of 4.6 FTE in 2016
2.8 FTE▼ 17.6%
Board2 names since 2010
1 director
Owners
99.73%
Documentsfilings and deeds
27-07-20264 days before the deadline
2025abbreviated format
Gross margin from €198,821 to €250,482Profit of €37,798, after a lossStaff from 3.4 FTE to 2.8 FTECompany renamed from AРОТЕЕК PRAATS to Zwitserse Apotheek 15-12Equity from €281,500 to €319,298

Key points

from the 2025 annual accounts

Result

€37,798 €37,798
-€20,4002024€37,8002025

Back in profit in 2025, after a loss of €20,375 in 2024.

Turnover

≈ €860,000 estimated

The abbreviated format states no turnover.

Filings

48 annual accounts since 1977
AprilJune31 JulyOctober1980199520102025

Five of the last ten came late. The 2019 accounts came in latest, 67 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as Zwitserse Apotheek has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for Zwitserse Apotheek. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 15-12-2023
  • 99.73%score equity €1.3m (2025) · annual accounts 2025 of
  • annual accounts 2019
Board & ownership

Recent changes

Company renamed from AРОТЕЕК PRAATS to Zwitserse Apotheek appointed as director · General meeting of 01-12-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0403785165
Amendment of the articles · Legal-form change · Resignations & appointments General meeting of 15-12-2023 · Gazette deed
Establishment taken over Zwitserse apoteek, Turnhoutsebaan 317, Wijnegem · in the KBO since 1961
All 60 events

Comparable companies

same main activity, similar in size and age
Company
Zwitserse Apotheek Wijnegem €531,646 €250,482 60.1% 2.8
SMETS PHARMA Lier €452,862 €273,890 53.4% 2.2
APOTHEEK VAN HULST Antwerp €613,381 €285,328 21.0% 2.5
APOTHEEK WARLOP Antwerp €455,699 €226,908 65.5% 3
APOTHEEK MATTHYSSEN Brasschaat €466,800 €282,271 74.1% 3.1
ThePharm Antwerp €593,897 €394,908 45.2% 2.8
Apoteek BEK Antwerp €441,724 €247,391 48.6% 2.5

These companies have the same main activity as Zwitserse Apotheek: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €442,000 and €613,000, founded between 1968 and 1986.

Official details

Source: KBO
Status
ActiveNormal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.004.638.4242110 Wijnegem, since 01-07-1961
Financial year end
31 December
Peppol
Reachable since 27-03-2025
Company details

Annual accounts 2025

€531,646▲ 6.8%
Employeeson 31-12-2025
3=
Filing
Filed on 27-07-2026, 4 days before the end of the filing period
Financials

Insights on Zwitserse Apotheek

Zwitserse Apotheek files the abbreviated format. That format states no turnover. The gross margin rose from €150,665 in 2006 to €250,482 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Zwitserse Apotheek

What is the company number of Zwitserse Apotheek?
The company number of Zwitserse Apotheek is 0403.785.165. The VAT number is the same number with BE in front: BE 0403.785.165.
Where is Zwitserse Apotheek based?
The registered office is at Turnhoutsebaan 317, 2110 Wijnegem.Company details
What does Zwitserse Apotheek do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Zwitserse Apotheek?
Zwitserse Apotheek is a private limited company (BV).
When was Zwitserse Apotheek founded?
Zwitserse Apotheek was founded on 01-01-1968.
Is Zwitserse Apotheek still active?
Yes, Zwitserse Apotheek is an active enterprise in the KBO register.
How many employees does Zwitserse Apotheek have?
Zwitserse Apotheek had an average of 2.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Zwitserse Apotheek fall under?
In its 2025 annual accounts, Zwitserse Apotheek states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Zwitserse Apotheek?
The turnover in financial year 2025 is ≈ €860,000. This figure is estimated from the gross margin of €250,482 and 42 comparable companies (NACE 477). It probably lies between €680,000 and €1.2m.
Is Zwitserse Apotheek profitable?
In financial year 2025, Zwitserse Apotheek made a profit of €37,798.
Where can I find the annual accounts of Zwitserse Apotheek?
Zwitserse Apotheek filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Zwitserse Apotheek due?
Zwitserse Apotheek must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.